1. Home
  2. STNG vs AMRX Comparison

STNG vs AMRX Comparison

Compare STNG & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scorpio Tankers Inc.

STNG

Scorpio Tankers Inc.

HOLD

Current Price

$78.40

Market Cap

3.9B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

N/A

Current Price

$18.09

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STNG
AMRX
Founded
2009
2002
Country
Monaco
United States
Employees
24
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
5.8B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
STNG
AMRX
Price
$78.40
$18.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$83.33
$15.60
AVG Volume (30 Days)
684.0K
1.8M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
2.22%
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.19
Revenue
N/A
N/A
Revenue This Year
$4.31
$4.48
Revenue Next Year
N/A
$7.13
P/E Ratio
$10.06
$94.32
Revenue Growth
N/A
N/A
52 Week Low
$43.78
$7.67
52 Week High
$87.39
$18.39

Technical Indicators

Market Signals
Indicator
STNG
AMRX
Relative Strength Index (RSI) 52.29 64.61
Support Level $72.53 $12.46
Resistance Level $80.30 $18.13
Average True Range (ATR) 2.56 0.57
MACD 0.33 -0.05
Stochastic Oscillator 64.14 78.87

Price Performance

Historical Comparison
STNG
AMRX

About STNG Scorpio Tankers Inc.

Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: